This ability has recently been successfully explored by us in a therapeutic vaccine model against tumor metastasis where we observed augmented tumor-specific CTL-induction, which agrees well with previous studies on CD103-targeted vaccine approaches and CT-adjuvant (M. Arabpour et al, unpublished data) 74,75. Here, ITGAE is linked to neoplasm.